The given chart illustrates the proportion of the drug comercial’s total trades in the range from 2002 to 2006 across three regions – America, Europe, Asia.
In 2002, America had the highest share of sales at 41%, while Europe and Asia encountered 34% and 25%, respectively. Over the years, America showed steadily decrease in prorportion and reached its minimum at 27%, but increased in 2006 to 30%. Europe had a steady growth from 2002 at 34% of sales till the 2004 at 38% and to the end of 2006 it showed fluctuated value, eventually reaching its minimal value at 30%. Asia had 25% in 2002 and increased steadily, reaching its peak in 2006 at 40% and making the highest sales among other regions in the final year.
Overall, the trend indicates a growing dominance of the Asian markets in the company’s sales, while America’s proportion decreased significantly over the time. Europe maintained a moderate but fluctuating share.